TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 0.400nMAssay Description:Inhibition of PDE4D (unknown origin)More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 3.20nMAssay Description:Inhibition of PDE4B2 (152 to 487 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 74nMAssay Description:Inhibition of PDE4D expressed in human U-937 cells using cAMP as substrateMore data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 180nMAssay Description:Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 1...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 400nMAssay Description:Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 1...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 490nMAssay Description:Inhibition of PDE4D (unknown origin)More data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 820nMAssay Description:Inhibition of PDE8A1 (480 to 820 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for ...More data for this Ligand-Target Pair
TargetcGMP-dependent 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 1.51E+3nMAssay Description:Inhibition of PDE2A (580 to 919 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 1...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 1.70E+3nMAssay Description:Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 1...More data for this Ligand-Target Pair
TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 1.76E+3nMAssay Description:Inhibition of PDE10A2 (449 to 770 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for...More data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 2.13E+3nMAssay Description:Inhibition of PDE7A1 (130 to 482 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 3.00E+3nMAssay Description:Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 1...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 3.10E+3nMAssay Description:Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 1...More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 4.25E+3nMAssay Description:Inhibition of PDE5A1 (535 to 860 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 4.70E+3nMAssay Description:Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 1...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 5.30E+3nMAssay Description:Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 1...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 5.70E+3nMAssay Description:Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 1...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 6.20E+3nMAssay Description:Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 1...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 7.30E+3nMAssay Description:Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 1...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 7.60E+3nMAssay Description:Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 1...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 1...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 1...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 1...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 1...More data for this Ligand-Target Pair
TargetHigh affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of PDE9A2 (181 to 506 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for ...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of PDE3A (679 to 1087 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for ...More data for this Ligand-Target Pair
TargetDual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of PDE1B (10 to 487 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 15...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 1...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 1.21E+4nMAssay Description:Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 1...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: >5.00E+4nMAssay Description:Inhibition of hERG by Q patch automated patch-clamp methodMore data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 6.84E+4nMAssay Description:Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 1...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 7.24E+4nMAssay Description:Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 1...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 8.00E+4nMAssay Description:Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 1...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 9.88E+4nMAssay Description:Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 1...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 1.01E+5nMAssay Description:Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 1...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 1.33E+5nMAssay Description:Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 1...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 1.77E+5nMAssay Description:Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 1...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 3.72E+5nMAssay Description:Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 1...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory Of Druggability And New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 6.03E+5nMAssay Description:Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 1...More data for this Ligand-Target Pair